Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +54.01%
#3 Glidr Glidr +41.01%
#4 Cysic Cysic +38.33%
#5 Walrus Walrus +27.54%
#6 Humanity Humanity +25.25%
#7 Enso Enso +17.24%
#8 Tutorial Tutorial +15.94%
#9 The Black Bull The Black Bull +14.95%
#10 Codatta Codatta +14.84%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Peringkat dalam Saham #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Harga Saham
$0.069
Terakhir disinkronkan: 2024-07-22
Kapitalisasi Pasar
$2.06M
Perubahan (1 hari)
-1.43%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan DermTech, Inc. (DMTK)

Kategori

Healthcare
Rasio P/E untuk DermTech, Inc. (DMTK)
Rasio P/E per August 2026 TTM: -0.03
Menurut laporan keuangan dan harga saham terbaru dari DermTech, Inc., rasio P/E saat ini (TTM) adalah -0.03. Pada akhir 2022, perusahaan memiliki rasio P/E sebesar -0.46.
Riwayat rasio P/E untuk DermTech, Inc. dari 2016 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
2026 (TTM) -0.03 -94.37%
2023 -0.54 17.86%
2022 -0.46 -92.18%
2021 -5.83 -61.42%
2020 -15.10 249.93%
2019 -4.32 -102.06%
2018 209.29 -100.01%
2017 -3.00M 4,455.00%
2016 -65.77K 0.00%
Rasio P/E untuk perusahaan serupa atau pesaing
Perusahaan Rasio P/E Perbedaan Rasio P/E Negara
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 31.59 -104,029.28%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 35.83 -117,968.09%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 -227.89 749,537.17%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 38.69 -127,373.03%
US
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.